Thank you Eli Lilly and Company for Inviting to Speak at the Lilly Oncology University / blood cancer, cancer, Eli Lilly and Company, Eric ...

HARMONi-2 shows ivonescimab improved median OS to 30.8 months versus 22.6 months with pembrolizumab in first-line ...

ABC8 Guidelines update advanced breast cancer care with new biomarker, ADC, endocrine, HER2, TNBC, exercise and ...

I Am Pleased to Announce UT MD Anderson’s 2026 Class of ECHO Scholars / Ana Refinetti, cancer, ECHO Scholars, ECHO Scholars ...

Reflecting on Eight Years of Service on Qatar’s National Cancer Governance Board / cancer, cancer care, Cancer Control, ...

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC / cancer, clinical trials, FDA ...

Lessons in Global Oncology and Access to Cancer Care / AIIMS New Delhi, cancer, OncoDaily, Oncoffee, Oncology, Vahe Grigoryan ...

What If We Are Missing Low-Level Targets That Are Rapidly Internalized? / ADC, Anton Safonov, Atif Ali Hashmi, Bo Liu, Bob Li ...

Nivolumab With deb-TACE in Liver-Limited Hepatocellular Carcinoma / cancer, cancer care, Cancer research, cancer treatment, ...

Can the gut microbiome shape response to cancer immunotherapy? Explore evidence linking gut bacteria, diet, antibiotics, FMT, ...

We Hosted a Wonderful Dinner Prior to Our Debbie's Dream Foundation / Amanda Pullinger, Anil Nagar, Bill Unwin, cancer, ...

Mendus Initiates Phase 1b DIVA Trial of Vididencel Plus Venetoclax and Azacitidine in Acute Myeloid Leukemia / Acute Myeloid ...